Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amenamevir milk transfer study during lactation
jRCTs031230591Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of Amenamevir in herpes simplex (HSV), sponsored by Maruho Co., Ltd. Primary endpoint: Relative infant dose based on milk average concentration over 24 hours. Started Mar 2024; status: completed.
02
Drugs
Amenamevir
03
Conditions
herpes simplex (HSV)
Beyond the preview
Go deeper on jRCTs031230591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031230591.